Alta Signa adds Westfield Specialty to capacity panel for D&O and FI risks

Reuters
01-28
Alta Signa adds Westfield Specialty to capacity panel for D&O and FI risks

By Rebecca Delaney

Jan 27 - (The Insurer) - European MGA Alta Signa has added Westfield Specialty International to its capacity panel, adding an additional €5mn ($5.24mn) of capacity for both D&O and financial institutions risks.

Headquartered in Brussels, Alta Signa is active in the European Economic Area and Switzerland across branch offices in seven countries.

The addition of Westfield Specialty International to its independent insurance capacity panel will enhance Alta Signa’s ability to underwrite D&O and financial institutions insurance risks across the EEA region and in Switzerland.

With €5mn D&O capacity and €5mn FI capacity added to the existing panel, Alta Signa’s insurance panel now includes Aviva, Axeria, Markel, SiriusPoint, Sompo and a trio of Lloyd’s syndicates (Aspen, Newline and Westfield Specialty International).

Gerard van Loon, CEO of Alta Signa, commented: "The addition of Westfield Specialty International to our panel is a significant milestone in Alta Signa’s journey to provide comprehensive and competitive insurance solutions in the specialty market.

"Westfield Specialty International’s expertise and robust capacity will complement our existing offerings and reinforce our ability to meet the evolving needs of brokers and clients across the EEA region and CH. We look forward to a productive partnership built on shared values of collaboration, integrity, and entrepreneurship."

James Johnston, management liability class underwriter at Westfield Specialty International, said: "We are excited to join Alta Signa’s independent capacity panel and bring our expertise to support their D&O and financial institutions portfolios across the EEA region and Switzerland. Together, we aim to provide brokers and policyholders with unparalleled access to robust and reliable coverage options."

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10